Israeli Startup Phantom GI Raises $5 Million for Minimally Invasive Bowel Stoma Device
Summarized from Haaretz English by baba
Israeli startup Phantom GI has raised $5 million to develop a device that creates a bowel stoma through a single puncture without surgery or general anesthesia. Founded by surgeons Eran Shlomovitz and Eliyahu Bechor, and CEO Ido Sadan, the company aims to provide a less invasive option for patients with bowel obstructions. The device is in preclinical trials, with human studies planned for early 2027 in Canada, followed by FDA approval efforts. This technology could significantly reduce treatment complexity and expand patient access.
The story in 6 lines · by baba
- Phantom GI raised $5 million to develop a minimally invasive stoma device.
- The device creates a bowel opening via a single skin puncture, avoiding surgery and general anesthesia.
- The technology is based on a technique developed by surgeon Dr. Eran Shlomovitz for a critically ill patient.
- An estimated 50,000 U.S. patients annually with bowel obstructions are too ill for conventional surgery.
- Phantom GI plans clinical trials in Canada starting early 2027, aiming for FDA approval.
- The device could eliminate the need for a second surgery to close a stoma.
Haaretz English publishes in English. The key points are summarized above. Read Haaretz English’s full report from the link at the top of the page.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Left 1Other 1
